{"id":20316,"date":"2019-02-11T10:32:53","date_gmt":"2019-02-11T07:32:53","guid":{"rendered":"http:\/\/www.tvturk.com\/index.php\/kanser-okulunda-hasta-ve-hasta-yakinlarina-egitim-verildi\/"},"modified":"2019-02-11T10:32:57","modified_gmt":"2019-02-11T07:32:57","slug":"kanser-okulunda-hasta-ve-hasta-yakinlarina-egitim-verildi","status":"publish","type":"post","link":"http:\/\/www.tvturk.com\/index.php\/kanser-okulunda-hasta-ve-hasta-yakinlarina-egitim-verildi\/","title":{"rendered":"Kanser okulunda hasta ve hasta yak\u0131nlar\u0131na e\u011fitim verildi"},"content":{"rendered":"

Kanser olgusu ile ilgili kayg\u0131y\u0131 azaltmak, kanser tedavisinin ba\u015far\u0131s\u0131nda erken te\u015fhisin \u00f6nemini vurgulamak, bu alanda fark\u0131ndal\u0131k olu\u015fturmak ve internetti bilgi kirlili\u011fini \u00f6n\u00fcne ge\u00e7mek amac\u0131yla hasta ve hasta yak\u0131nlara Memorial Kanser Okulu\u2019nda e\u011fitim verildi.<\/p>\n

Toplumun, kanserle tan\u0131\u015fmadan onunla y\u00fczle\u015fmesini sa\u011flamak i\u00e7in Memorial Kanser Okulu, kanserle m\u00fccadeleye \u2019e\u011fitim\u2019 kimli\u011fi kazand\u0131r\u0131yor. Kanser olgusu ile ilgili kayg\u0131y\u0131 azaltmak, kanser tedavisinin ba\u015far\u0131s\u0131nda erken te\u015fhisin \u00f6nemini vurgulamak ve bu alanda fark\u0131ndal\u0131k olu\u015fturmak amac\u0131yla hasta ve hasta yak\u0131nlar\u0131n\u0131 bir araya getirmeyi ama\u00e7layan kanser okulunun Memorial Bah\u00e7elievler Hastanesi\u2019nde ilk program\u0131n\u0131 ger\u00e7ekle\u015ftirdi. Programda kanserde t\u0131bbi g\u00f6r\u00fcnt\u00fcleme alan\u0131nda Prof. Dr. Ak\u0131n Y\u0131ld\u0131z, kanserde \u0131\u015f\u0131n tedavisi hakk\u0131nda Prof. Dr. Fazilet \u00d6ner Din\u00e7ba\u015f, kanserde ila\u00e7 tedavileri hakk\u0131nda ise Do\u00e7. Dr. Kezban Nur Pilanc\u0131 bilgiler verdi. Program, doktorlar\u0131n kanser ve tedavisi hakk\u0131nda bilgilendirme yapmas\u0131 ard\u0131ndan soru-cevap \u015feklinde devam etti.<\/p>\n

\u2019\u2019Do\u011fru bilgiyi halk\u0131m\u0131za sunaca\u011f\u0131z\u2019\u2019<\/p>\n

Kanser hakk\u0131nda do\u011fru bilgi edinmenin \u00f6nemine dikkat \u00e7eken Prof. Dr. Ak\u0131n Y\u0131ld\u0131z, \u2019\u2019Kanserle ilgili son y\u0131llarda son derece \u00f6nemli geli\u015fmeler var. Fakat ayn\u0131 zamanda bu bilimsel geli\u015fmelere kar\u015f\u0131n son derece kafa kar\u0131\u015f\u0131kl\u0131\u011f\u0131 olu\u015fturan bilgi kirlili\u011fi de var. Biz, topluma kar\u015f\u0131da bu anlamda sorumlu hissetti\u011fimiz i\u00e7in halka y\u00f6nelik bu bilgilendirme toplant\u0131lar\u0131n\u0131 birebir kar\u015f\u0131l\u0131kl\u0131 g\u00f6r\u00fc\u015ferek ekibimizde hocalar\u0131m\u0131zla yapmak istedik. D\u00fczenli bir program haz\u0131rlad\u0131k. \u0130lki e\u011fitim; genel bir tan\u0131t\u0131m, kanserle ilgili g\u00f6r\u00fcnt\u00fcleme, radyoterapi ve molek\u00fcler tedaviler ve kemoterapi ve yeni ba\u015flayan baz\u0131 ila\u00e7larla ilgili arkada\u015flar\u0131m\u0131z\u0131n bilgi vermesi \u015feklinde oldu. Amac\u0131m\u0131z bilgi kirlili\u011fini ortadan kald\u0131rmaya \u00e7al\u0131\u015fmak ve halk\u0131m\u0131z\u0131 ayd\u0131nlatmaya \u00e7al\u0131\u015fmak. Bunun \u00f6nemli bir misyonu oldu\u011funu d\u00fc\u015f\u00fcn\u00fcyoruz. E\u011fitimlerimiz farkl\u0131 ba\u015fl\u0131klar alt\u0131nda olacak. Meme kanseri, kal\u0131n ba\u011f\u0131rsak, gastrointestinal kanserler akci\u011fer kanseri gibi spesifik konularla bunlar\u0131 \u00f6n\u00fcm\u00fczdeki d\u00f6nemde ayl\u0131k olarak yapmay\u0131 planl\u0131yoruz. Bu konularda son derece yetkin bir akademik kadrodan olu\u015fan b\u00fcy\u00fck bir ekibiz. Bu alandaki t\u00fcm bilgilerimizi halk\u0131m\u0131zla payla\u015fmak i\u00e7in e\u011fitimlerimiz devam edecek\u2019\u2019 dedi.<\/p>\n

\u2019\u2019G\u00f6r\u00fcnt\u00fcleme k\u0131sm\u0131 yan\u0131nda radyoaktif maddelerle tedaviler yeni yeni geli\u015fmeye ba\u015flad\u0131\u2019\u2019<\/p>\n

N\u00fckleer t\u0131bb\u0131n kanser tedavisindeki yerini de\u011ferlendiren Prof. Dr. Y\u0131ld\u0131z, \u2019\u2019N\u00fckleer t\u0131bb\u0131n alan\u0131nda radyoaktif maddelerin tan\u0131 ve tedavi amac\u0131yla kullan\u0131lmas\u0131 s\u00f6z konusu. Olduk\u00e7a eski bir alan. Y\u00fcz y\u0131ll\u0131k bir ge\u00e7mi\u015fe dayal\u0131 ilk uygulama ba\u015flang\u0131c\u0131 diyebiliriz. Son y\u0131llarda g\u00f6r\u00fcnt\u00fcleme ve tedavi alan\u0131nda \u00e7ok \u00f6nemli geli\u015fmeler oldu. G\u00f6r\u00fcnt\u00fclemede \u00f6zellikle 2000 y\u0131l\u0131nda ba\u015flayan bir s\u00fcre\u00e7 var ki, bu s\u00fcre\u00e7te PET-CT dedi\u011fimiz bir y\u00f6ntem s\u00f6z konusu. PET-CT, 2000 y\u0131l\u0131 uygulamayla beraber kanserde, kanser g\u00f6r\u00fcnt\u00fclenmesinde, evrelendirmesinde, tedavi yan\u0131t\u0131nda bir devrime yol a\u00e7t\u0131. Yeni yeni \u00e7\u0131kan baz\u0131 molek\u00fcllerle molek\u00fcler g\u00f6r\u00fcnt\u00fcleme dedi\u011fimiz farkl\u0131 bir alana ge\u00e7ilmi\u015f oldu. G\u00f6r\u00fcnt\u00fcleme k\u0131sm\u0131 yan\u0131nda radyoaktif maddelerle tedaviler yeni yeni geli\u015fmeye ba\u015flad\u0131. Eskiden beri tiroit kanserinde uygulanan hedefe y\u00f6nelik ak\u0131ll\u0131 bir tedavi vard\u0131. Bunun \u00e7ok daha farkl\u0131 bi\u00e7imleri ortaya \u00e7\u0131kmaya ba\u015flad\u0131. \u015eimdi molek\u00fcler tedavi olarak yeni bir alan olarak isimlendirilmeye ba\u015flad\u0131. Prostat kanserinde \u00f6rne\u011fin \u00e7ok daha iyi g\u00f6r\u00fcnt\u00fcleme ve yine yeni molek\u00fcler PSA dedi\u011fimiz bir molek\u00fclle prostat kanseri tedavisinde de \u00e7ok \u00f6nemli geli\u015fmeler ya\u015fanacak gibi g\u00f6r\u00fcn\u00fcyor. Ayn\u0131 molek\u00fclle farkl\u0131 bir bile\u015fik elde ederek tedavi etme \u015fans\u0131 yakaland\u0131. Bu geli\u015fmeler h\u0131zla devam ediyor ve bunlar\u0131 halk\u0131m\u0131zla payla\u015fmak istiyoruz\u2019\u2019a\u00e7\u0131klamas\u0131nda bulundu.<\/p>\n

Kanser e\u011fitiminde nelerin ama\u00e7land\u0131\u011f\u0131 konusunda a\u00e7\u0131klama yapan Do\u00e7. Dr. Kezban Nur Pilanc\u0131, \u2019\u2019\u0130\u00e7inde bulundu\u011fumuz ay kanser ay\u0131 ve kanser ay\u0131nda bizde fark\u0131ndal\u0131k olu\u015fturmak amac\u0131yla hastane olarak bir kanser okulu d\u00fczenledik. Bu okulu d\u00fczenlemedeki amac\u0131m\u0131z; \u00f6ncelikli olarak kanserin tan\u0131s\u0131. Kanser tan\u0131s\u0131 konulduktan sonra tedaviye nas\u0131l karar veriyoruz, nas\u0131l bir ekiple karar veriyoruz? Bunlar\u0131 konu\u015fmak i\u00e7in buradayd\u0131k. Tedavi se\u00e7enekleri ise; elimizdeki en \u00f6nemli ila\u00e7lardan biri olan klasik kemoterapi ila\u00e7lar\u0131, ak\u0131ll\u0131 ila\u00e7lar, imm\u00fcnoterapiler, hormonoterapiler ve ard\u0131ndan radyoterapi. G\u00f6r\u00fcnt\u00fcleme y\u00f6ntemlerinde nelere dikkat ediyoruz ve hangi g\u00f6r\u00fcnt\u00fcleme y\u00f6ntemlerini kullan\u0131yoruz? Bunlardan da e\u011fitimizden bahsettik\u2019\u2019 \u015feklinde konu\u015ftu.<\/p>\n

\u2019\u2019Tedavi karar\u0131n\u0131 multidisipliner konsey veriyor\u2019\u2019<\/p>\n

Kanser tan\u0131l\u0131 hastalara tedavi karar\u0131 verirken multidisipliner bir konsey taraf\u0131ndan karar verildi\u011fini dile getiren Do\u00e7. Dr. Pilanc\u0131, \u2019\u2019K\u0131saca hastalar\u0131m\u0131za da bu konseyde neler yap\u0131yoruz, tedavi karar\u0131 nas\u0131l al\u0131yoruz bunlar\u0131 anlatmak istedik. Her ay sonunda mutlaka toplanaca\u011f\u0131z. Medikal onkoloji olarak kulland\u0131\u011f\u0131m\u0131z tedavi y\u00f6ntemleri aras\u0131nda ak\u0131ll\u0131 ila\u00e7lar yani hedefli tedaviler, imm\u00fcnoterapi ve hormonoterapiden k\u0131saca bahsettik. Her hastaya ayn\u0131 tedaviyi mi veriyoruz? Tedaviyi nas\u0131l bireyselle\u015ftiriyoruz? En b\u00fcy\u00fck katk\u0131y\u0131 hastam\u0131za nas\u0131l sa\u011flayabiliriz? K\u0131saca bu konulara de\u011findik\u2019\u2019 ifadelerini kulland\u0131.

\"Kanser <\/a> <\/div> <\/div>
\"Kanser <\/a> <\/div>
\"Kanser <\/a> <\/div> <\/div> <\/div>
\"Kanser <\/a> <\/div> <\/div>
\"Kanser <\/a> <\/div> <\/div> <\/div> <\/div><\/p>\n","protected":false},"excerpt":{"rendered":"

KANSER OLGUSU \u0130LE \u0130LG\u0130L\u0130 KAYGIYI AZALTMAK, KANSER TEDAV\u0130S\u0130N\u0130N BA\u015eARISINDA ERKEN TE\u015eH\u0130S\u0130N \u00d6NEM\u0130N\u0130 VURGULAMAK, BU ALANDA FARKINDALIK OLU\u015eTURMAK VE \u0130NTERNETT\u0130 B\u0130LG\u0130 K\u0130RL\u0130L\u0130\u011e\u0130N\u0130 \u00d6N\u00dcNE GE\u00c7MEK AMACIYLA HASTA VE HASTA YAKINLARA MEMOR\u0130AL KANSER OKULU’NDA E\u011e\u0130T\u0130M VER\u0130LD\u0130.<\/p>\n","protected":false},"author":1,"featured_media":20317,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[658],"tags":[398,4166,350,1970,634,8894],"class_list":["post-20316","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-egitim","tag-hasta","tag-kanser","tag-okulunda","tag-verildi","tag-yakinlarina"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.tvturk.com\/wp-content\/uploads\/2019\/02\/kanser-okulunda-hasta-ve-hasta-yakinlarina-egitim-verildi_59ad045.jpg?fit=1000%2C666","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/paKIfm-5hG","_links":{"self":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/posts\/20316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/comments?post=20316"}],"version-history":[{"count":1,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/posts\/20316\/revisions"}],"predecessor-version":[{"id":20323,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/posts\/20316\/revisions\/20323"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/media\/20317"}],"wp:attachment":[{"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/media?parent=20316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/categories?post=20316"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.tvturk.com\/index.php\/wp-json\/wp\/v2\/tags?post=20316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}